Zevra Therapeutics Inc (ZVRA)
4.73
-0.03
(-0.63%)
USD |
NASDAQ |
May 17, 16:00
4.73
0.00 (0.00%)
Pre-Market: 20:00
Zevra Therapeutics Cash from Operations (TTM): -45.66M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -45.66M |
December 31, 2023 | -33.54M |
September 30, 2023 | -21.84M |
June 30, 2023 | -23.81M |
March 31, 2023 | -19.21M |
December 31, 2022 | -18.72M |
September 30, 2022 | -15.10M |
June 30, 2022 | -11.24M |
March 31, 2022 | 9.472M |
December 31, 2021 | 10.44M |
September 30, 2021 | 10.23M |
June 30, 2021 | 11.91M |
March 31, 2021 | -2.503M |
December 31, 2020 | -1.939M |
September 30, 2020 | -3.978M |
June 30, 2020 | -5.156M |
March 31, 2020 | -14.69M |
December 31, 2019 | -23.74M |
September 30, 2019 | -35.64M |
Date | Value |
---|---|
June 30, 2019 | -49.36M |
March 31, 2019 | -51.17M |
December 31, 2018 | -54.20M |
September 30, 2018 | -46.14M |
June 30, 2018 | -40.36M |
March 31, 2018 | -37.68M |
December 31, 2017 | -33.10M |
September 30, 2017 | -35.52M |
June 30, 2017 | -33.63M |
March 31, 2017 | -35.43M |
December 31, 2016 | -29.77M |
September 30, 2016 | -26.82M |
June 30, 2016 | -23.15M |
March 31, 2016 | -20.13M |
December 31, 2015 | -20.27M |
September 30, 2015 | -20.83M |
June 30, 2015 | -20.10M |
March 31, 2015 | -17.78M |
December 31, 2014 | -14.67M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-49.36M
Minimum
Jun 2019
11.91M
Maximum
Jun 2021
-14.20M
Average
-14.90M
Median
Cash from Operations (TTM) Benchmarks
Perspective Therapeutics Inc | -13.34M |
Dare Bioscience Inc | -29.55M |
OptiNose Inc | -32.08M |
Kodiak Sciences Inc | -146.56M |
INmune Bio Inc | -18.32M |